LONDON – Pfizer (NYSE: PFE) and Moderna’s (NASDAQ: MRNA) legal battle over their rival COVID-19 vaccines will continue after London’s
1 year ago
2seventy Bio (NASDAQ: TSVT) will discontinue enrolling patients in a late-stage study of its cell therapy Abecma, developed in partnership
BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United
Sanofi (NASDAQ: SNY) has received two separate bids from private equity firms for its consumer health unit, which could be
WASHINGTON – On Tuesday, U.S. Senator Bernie Sanders said he had commitments from the nation’s top pharmacy benefit managers that
NEW YORK – Sanofi’s (NASDAQ: SNY) chief executive, Paul Hudson, said in an interview on Monday that the company is
Novo Nordisk’s (NYSE: NVO) chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the
On Friday, the U.S. Food and Drug Administration said it has approved the use of a drug combination along with
A Johnson & Johnson (NYSE: JNJ) subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant
The U.S. Federal Trade Commission sued the country’s three largest pharmacy benefit managers on Friday, accusing them of steering diabetes
On Friday, a U.S. appeals court revived a lawsuit by healthcare and drug industry groups challenging the first-ever U.S. law
FRANKFURT – On Friday, Sanofi (NASDAQ: SNY) said that its multiple sclerosis drug candidate was shown to delay the worsening
